ROCKVILLE, Md., July 25, 2024--GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory ...

After hours: September 27 at 7:59 PM EDT Loading Chart for GLYC ...

After hours: 30 August at 18:07 GMT-4 ...

After hours: 27 September at 19:59 GMT-4 ...

View GlycoMimetics, Inc. (GLYC) current and estimated P/E ratio data provided by Seeking Alpha.

Many natural gas investments aren't for beginners due to their volatility, but they have the potential to outperform the stock market.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

As of September 20, 2024, GlycoMimetics Inc had a $10.6 million market capitalization, putting it in the 15th percentile of companies in the Biotechnology & Medical Research industry. GlycoMimetics ...